Rosuvastatin prevents aortic arch plaque progression and improves prognosis in ischemic stroke patients.

DISCUSSION: Rosuvastatin therapy prevented aortic arch plaque progression in IS patients with CAP, and may also have long-term clinical benefits. PMID: 27915586 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/27915586?dopt=Abstract

Source: Neurological Research - December 7, 2016 Category: Neurology Tags: Neurol Res Source Type: research